On January 7, 2026, Rapport Therapeutics, Inc. announced the accelerated initiation of its RAP-219 Program and an expansion of its epilepsy portfolio, along with a corporate presentation available on their website.
AI Assistant
RAPPORT THERAPEUTICS INC
2026
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.